We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Avacta Group Plc | LSE:AVCT | London | Ordinary Share | GB00BYYW9G87 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.80 | 1.80% | 45.30 | 45.00 | 45.50 | 45.75 | 43.25 | 44.75 | 4,437,570 | 16:35:10 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 10.06M | -39.19M | -0.1382 | -3.27 | 128.34M |
Date | Subject | Author | Discuss |
---|---|---|---|
24/1/2020 15:19 | Heavy volume again. | x54v | |
24/1/2020 15:14 | Daewoong on there too. Were LG so impressed they introduced Avacta to Daewoong ? | the stigologist | |
24/1/2020 15:08 | Would buy the 4000LG Chem Life-science has been making a lot of noises about working even more with their partners and gaining global market share via their partners and investors.Avacta features prominently in their presentation.https:/ | nordic1958 | |
24/1/2020 14:01 | Helps to see the trades / volume... | someuwin | |
24/1/2020 13:43 | "Avacta Group revenues rocket with order intake and sales pipeline strongest to date" | x54v | |
24/1/2020 13:31 | Can buy £4k online. But not £5k. | someuwin | |
24/1/2020 10:35 | Yes we saw it the first time around, but you are right.Here is a Ceo who can barely hide his excitement over the forthcoming deals and the interest there is in AVA6000.The trading statement says it as well.Watch the share price!! | nordic1958 | |
24/1/2020 10:06 | You love to see it Avacta twitter account on a mission to get their great story out there | the stigologist | |
24/1/2020 09:50 | He's correct. I think this looks a $Billion + platform tech as a $300m deal with just one partner LG might suggest This one off sale thanks to Woodford won't last long | the stigologist | |
24/1/2020 08:41 | Myles McNulty loading up 'Another 100k #AVCT shares for me has nudged it into my 2nd largest position, behind RRE. Would like to add more when cash is freed up elsewhere. Carried out significant research into this: incredible near-term potential uplift, but I'm more interested in its 3-5 year potential.' | tromso1 | |
24/1/2020 08:26 | I agree, the comparable valuation to it's US peer group, would suggest a price several times it's current value.Clearly the Health care conference was a big success and as suggested, more follow up deals to come!! | nordic1958 | |
24/1/2020 08:21 | Plenty of cash... "This cash sees us all the way through into 2021 as we set out at the fundraise last year. So other partner programs are fully funded by the partners so we have more than 12 months cash runway now as we set out last year." | x54v | |
24/1/2020 08:11 | Far more important that the Brokers target price is the reasoning behind and justification for the value In the case of AVCT it is actually even better than the Brokers target price Equivalent 'platform technology' Companies in the US are valued at 4 to 12 times AVCT And we have major valuation inflection points coming this year | the stigologist | |
24/1/2020 07:09 | Oh look. StockStracker has mixed it up a bit by posting the same link to his twitter feed from yet another of his aliases.. | dplewis1 | |
24/1/2020 06:51 | Cash 8.7million. They raised 9 million recently | letmepass | |
23/1/2020 16:58 | AgreeKeep an eye on the shareholder register,any further announcements ref AVA6000 Could cause Avacta in a new range, 40% above current range.The Koreans have made it very clear that they are looking expand and work with Avacta.Let us look to have more post JPM week results.ADC's big partner and shareholder is Astra Zeneca,they work with LG as well, Avacta will gain traction and attention from the well known majors.Remember we have IPO from ADC to be announced at some stage. | nordic1958 | |
23/1/2020 16:46 | Well, I am in and will be looking to add once we break and hold above 20p. I see that as short term resistance. IMHO. | m5 | |
23/1/2020 16:22 | Hmm, is the worm beginning to turn? Looking at 2.5m volume on the day plus any late reported trades. Regardless of overhang, the stock is certainly now gaining attention. | bumpa33 | |
23/1/2020 15:38 | What is key that the cash position is well positioned into 2021.Avacta's research and development costs will be fully covered by the joint venture which is funded by Daewoong. Avacta retains the rights to commercialise the Affimer proteins outside of the field of cell therapies.Avacta have the same with LG Chem and ADC.It would be foolish to rule out any further JV's during the year,judging from the very upbeat trading statement from the CEO.Would buy more before it is too late. | nordic1958 | |
23/1/2020 11:45 | Agree!!How do one get to cash position of £7mill, when the company clearly states £8.7 mill.!!!Order/revenu | nordic1958 | |
23/1/2020 10:53 | "We maintain our target price of 76p." Massive upside from the current price. Strong update today. Overhang clearing rapidly and providing a great opportunity to get in on the cheap. | x54v |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions